BCL-2 antisense (G3139) plus docetaxel for treatment of progressive androgen-independent prostate cancer
Publication/Presentation Date
4-2001
Volume
37
Issue
6
First Page
218
Last Page
219
Published In/Presented At
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
Department(s)
Administration and Leadership
Document Type
Article
COinS